Stay updated on Expanded Access of Lifileucel in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.

Latest updates to the Expanded Access of Lifileucel in Melanoma: Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.2 from v3.2.0. This appears to be a page version update rather than a modification to study details or content.SummaryDifference0.0%

- Check10 days agoChange DetectedThe government funding/operating status notice was removed from the page; no other content changes were made.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- No modifications detected to core study information (title, conditions, intervention, eligibility, and locations). The page content remains as previously presented.SummaryDifference0.2%

- Check53 days agoChange DetectedUpdated to v3.2.0 with a government-status notice; removed v3.1.0.SummaryDifference5%

- Check60 days agoChange DetectedThe page has updated its version to v3.1.0 and added a contact phone number (844-845-4682); it no longer references v3.0.2.SummaryDifference0.1%

- Check74 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. This does not affect core content, pricing, or any time-sensitive information.SummaryDifference0.3%

Stay in the know with updates to Expanded Access of Lifileucel in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.